专利检索 ap:("Qurient Co. Ltd.") AND inv:"JUNG, Chunwon" 第 1 页

1.

发明公开
DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE 审中-公开

公开(公告)号：EP4003521A1

公开(公告)日：2022-06-01

申请号：EP19756324.0

申请日：2019-07-30

申请人： Qurient Co. Ltd.

发明人： NAM, Kiyean , KIM, Jaeseung , JUNG, Chunwon , LEE, Saeyeon

IPC分类号： A61P31/04 , A61P31/06 , C07D471/04 , A61K31/437

2.

发明公开
A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203 审中-公开

公开(公告)号：EP4431114A2

公开(公告)日：2024-09-18

申请号：EP24176555.1

申请日：2020-12-17

申请人： Qurient Co. Ltd.

发明人： NAM, Kiyean , KIM, Jaeseung , JUNG, Chunwon , LEE, Saeyeon

IPC分类号： A61K47/26

CPC分类号： A61K31/437 , A61K9/2866 , A61K47/38 , A61K47/32 , A61K47/26

摘要： The present invention relates to new pharmaceutical dosage forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide, in particular of its ditosylate form.

3.

发明公开
A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203 审中-公开

公开(公告)号：EP4431114A3

公开(公告)日：2024-11-13

申请号：EP24176555.1

申请日：2020-12-17

申请人： Qurient Co. Ltd.

发明人： NAM, Kiyean , KIM, Jaeseung , JUNG, Chunwon , LEE, Saeyeon

IPC分类号： A61K31/437 , A61K9/28 , A61K47/38 , A61K47/32 , A61K47/26 , A61K9/20 , A61P31/04 , A61P31/06

摘要： The present invention relates to new pharmaceutical dosage forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide, in particular of its ditosylate form.

4.

发明公开
DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE 审中-公开

公开(公告)号：EP4427748A2

公开(公告)日：2024-09-11

申请号：EP24176134.5

申请日：2019-07-30

申请人： Qurient Co. Ltd.

发明人： NAM, Kiyean , KIM, Jaeseung , JUNG, Chunwon , LEE, Saeyeon

IPC分类号： A61K31/437

CPC分类号： C07D471/04 , A61P31/04 , A61P31/06

摘要： The present invention relates to different forms of the compound 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide and to methods of making such forms/compounds. The present invention furthermore relates to mono-acid addition salts thereof, to methods of making such mono-acid addition salts and to pharmaceutical compositions comprising any of the aforementioned compounds. Furthermore, the present invention relates to uses of any of these compounds.

5.

发明公开
A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING ZILEUTON 审中-公开

公开(公告)号：EP4057995A1

公开(公告)日：2022-09-21

申请号：EP19832158.0

申请日：2019-12-30

申请人： Qurient Co. Ltd.

发明人： NAM, Kiyean , KIM, Jaeseung , JUNG, Chunwon , CHUN, Jiyoong , JEON, Borami

IPC分类号： A61K9/06 , A61K31/381 , A61K47/14 , A61P17/00 , A61P17/06